Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume 11, Issue 3, Pages 521-528Publisher
WILEY
DOI: 10.1111/jth.12120
Keywords
antiphospholipid syndrome; autoimmune diseases; GAIT Project; genome-wide association study; hemostasis; 2-glycoproteinI
Categories
Funding
- Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria [PI-11/00184, PI-08/0420, PI-08/0756, RECAVA-RD06/0014]
- Ministerio de Ciencia e Innovacion [SAF2008/01859]
- Agencia de Gestio d'ajuts Universitaris i de Recerca [SGR 2009-1240]
- Subprograma Nacional de Contratacion e Incorporacion de Investigadores Juan de la Cierva (MICINN)
- European Community Sixth Framework Program [LSHM-CT-2007-037273]
- AstraZeneca
- British Heart Foundation
- Wellcome Trust [075491/Z/04]
- Swedish Research Council
- Knut and Alice Wallenberg Foundation
- Swedish Heart-Lung Foundation
- Torsten and Ragnar Soderberg Foundation
- Karolinska Institutet
- Stockholm County Council
- Foundation for Strategic Research
- European Union [PIEF-GA-2009-252361]
Ask authors/readers for more resources
Background 2-GlycoproteinI (2-GPI), also designated apolipoproteinH, is a 50-kDa protein that circulates in blood at high concentrations, playing important roles in autoimmune diseases, hemostasis, atherogenesis, and angiogenesis, as well as in host defense against bacteria and in protein/cellular waste removal. Plasma 2-GPI levels have a significant genetic component (heritability of similar to 80%). Objectives To present the results of a genome-wide association study for plasma 2-GPI levels in a set of extended pedigrees from the Genetic Analysis of Idiopathic Thrombophilia (GAIT) Project. Patients/Methods A total of 306 individuals for whom 2-GPI plasma measurements were available were typed for 307984 single-nucleotide polymorphisms (SNPs) with the Infinium 317k Beadchip (Illumina). Association with the 2-GPI phenotype was investigated through variance component analysis, and the most significant results were followed up for association with coronary artery disease (CAD) in an independent insilico analysis involving 5765 CAD cases from the PROCARDIS Project and 7264 controls from the PROCARDIS Project and the Wellcome Trust Case Control Consortium (WTCCC) collection. Results After correction for multiple testing, three SNPs located in/around two genes (ELF5 and SCUBE2) reached genome-wide significance. Moreover, an SNP in the APOH gene showed suggestive association with the 2-GPI phenotype. Some of the identified genes are plausible biological candidates, as they are actually or potentially involved in inflammatory processes. Conclusions Our results represent a first step towards identifying common variants reflecting the genetic architecture influencing plasma 2-GPI levels, and warrant further validation by functional experiments, as the functions of some of the discovered loci are still unknown.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available